Drug Information Resources Lecture No:2 Smitha C Francis.

19
Drug Information Resources Lecture No:2 Smitha C Francis

Transcript of Drug Information Resources Lecture No:2 Smitha C Francis.

Page 1: Drug Information Resources Lecture No:2 Smitha C Francis.

Drug Information Resources

Lecture No:2Smitha C Francis

Page 2: Drug Information Resources Lecture No:2 Smitha C Francis.

Drug Information resources

• Tertiary sources• Secondary sources• Primary sources• Internet • Alternative information resources• Consumer health information

Page 3: Drug Information Resources Lecture No:2 Smitha C Francis.

Tertiary sources• Textbooks, data bases, review articles in journalsBenefits:- - Easy and convenient access to a broad spectrum of topics. - Background information on drugs and diseases. - Answer many drug related problems, excellent first line resources.Limitations:- - Lag time associated with publication. - Incomplete information, human bias. - lack of expertise by authors- misinterpretation of primary and secondary literature.

Page 4: Drug Information Resources Lecture No:2 Smitha C Francis.

Databases - convenient, easy to use, referenced - similar to text books - updated more frequentlye.g. Micromedex, Clinical Pharmacology on

Hand, Lexi-comp on Hand

Page 5: Drug Information Resources Lecture No:2 Smitha C Francis.

General considerations while using tertiary sources

• Author, publisher• Year of publication or last revision date• Edition of the text• Bibliography• Scope – how accessible is the information• Alternative resources

Page 6: Drug Information Resources Lecture No:2 Smitha C Francis.

Tertiary resources

Page 7: Drug Information Resources Lecture No:2 Smitha C Francis.

Secondary resources

• References that either index or abstract the primary literature with the goal of directing the user to the primary literature.

• Benefits:-• Quick and selective screening of primary resources for

specific information, data , citation and articles.• May provide sufficient information to serve as references

for answering DI requests. • Medline/pubmed, International pharmaceutical abstracts ,

Iowa drug Information system.• Vast majority of these resources are utilized primarily in an

electronic format although still some may have a print form.

Page 8: Drug Information Resources Lecture No:2 Smitha C Francis.

Limitations:-• Review of finite number of journals- hinder the

thoroughness of a literature search.• lag time- publication and citation in an index.• Describe only articles and clinical studies from

journals, addition of new information through letters which are not included in the services- Medline/Pubmed, Iowa DI services

• Used to locate journal articles. Abstracts - no enough information to critically evaluate the study.

Page 9: Drug Information Resources Lecture No:2 Smitha C Francis.

Secondary resources

Page 10: Drug Information Resources Lecture No:2 Smitha C Francis.

Primary literature• Journals• Consists of clinical research studies and reports, both published and

unpublished.( Controlled trials, case series, case reports)• Not all articles published in a journal are primary literature.(review articles,

articles of opinion, correspondence, special reports) Journals enable pharmacists to:- - Keep abreast of professional news, new developments in pathophysiology, diagnostic agents, and therapeutic regimens. - distinguish useful from useless or even harmful therapy. - enhance communication with other health care professionals and consumers. - Share opinions with other healthcare professionals through letters to the editor.

Page 11: Drug Information Resources Lecture No:2 Smitha C Francis.

Advantages: -• Access to detailed information about a topic.• Ability to personally assess the utility and validity of study results.• More recent information than tertiary or secondary literature.Disadvantages:-• Does not guarantee that an article is accurate, misleading conclusions based on only one trial without the context of other researches• Need to have good skills in medical literature evaluation, time needed to evaluate the large volume of literature.

Page 12: Drug Information Resources Lecture No:2 Smitha C Francis.

Primary resources

Page 13: Drug Information Resources Lecture No:2 Smitha C Francis.

Tertiary Secondary Primary

Nature Textbooks, general references, review articles

Intermediary between texts & primary resources–indexing and abstracting services

Original research –clinical trials & case reports

Examples Therapeutic Guidelines, Micromedex

International Pharmaceutical Abstracts, Medline/ Pubmed

JAMA, NEJM

Advantages Easy and convenient access to

broad range of information

Quick and easy selective screening of primary literature

for specific information

Most current information

Helps to answer specific questions

Reputable sources are peer-reviewed

LimitationsInformation may not be recent

Information omissions

Information misinterpretation

Source/intent of information

Usually describe content from journals .

Mainly used to locate relevant journals

A lot of information to go through and absorb

No guarantee of accuracy

Page 14: Drug Information Resources Lecture No:2 Smitha C Francis.

InternetAnother method to identify relevant resource.Benefits:-• Ability to search therapies that have been recently

published or discussed in the media.• Most popular web browsers- Mozilla Firefox, Microsoft

internet explorer,• Search engines- Google, altavista, Yahoo- index as much of

the internet as possible.Limitations:-• Information may not be peer reviewed or edited before

release.• A website should be evaluated by its source of

information.• Literature evaluation skills should be used to determine

whether information is clear, relevant and referenced.

Page 15: Drug Information Resources Lecture No:2 Smitha C Francis.

www.lexisnexis.com

• Inorder to assess the quality of online information, several standards and programs exist. (www.hon.ch)

Alternative information sources: www.cnn.com www.healthnewsdaily.com www.prnewswire.com www.reutershealth.com

Page 16: Drug Information Resources Lecture No:2 Smitha C Francis.

Consumer health information

website Maintained by Content

www.medlineplus.gov

National library of medicine

Medications, disease states and conditions

www.fda.gov

Food and drug administration

New drugs and dietary supplements and recalls of drug or food.

Page 17: Drug Information Resources Lecture No:2 Smitha C Francis.

Drug information resources - Texts and References

• Adverse drug reactions- AHFS DI, DrugDex, Martindale’s : The Extra Pharmacopoeia, Side effects of Drugs.

• Alternative Medicines- Review of natural products, professional’s Handbook of Complementary and Alternative Medicine

• Doses- Drugs Facts and Comparisons, Physician’s Drug Reference.• Pediatric- Pediatric Drug Handbook• Drug Identification- Drugs Facts and Comparisons, Identidex,

Lexicomp, Merck Index, European Drug Index.• Drug Interactions- AHFS DI, USP DI• Indications- Pharmacotherapy, Drug Information Handbook• Teratogenecity- Drugs in Pregnancy and Lactation, ReproRisk,

AHFS DI.

Page 18: Drug Information Resources Lecture No:2 Smitha C Francis.

Conclusion All pharmacists must be effective DI providers regardless of

their practice.

An effective provider perceives, assesses and evaluates DI needs and retrieves, evaluates, communicates and applies data from the resources as an integral component of patient care.

There is still the need for practitioner to have support from DICs to meet special information needs, to serve as a resource on effective medication use, and to assist pharmacy practitioners as well as others in solving medication therapy situations.

Page 19: Drug Information Resources Lecture No:2 Smitha C Francis.

References

• Drug Information – A guide for Pharmacists.• A textbook of clinical pharmacy, essential concepts and skills.